Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-25

Clinical Trial Update: Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating EBA of meropenem with amoxicillin/clavulanate and pyrazinamide or bedaquiline in adults with pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Meropenem (Meropenem)
  • Pyrazinamide (pyrazinamide)
  • amoxicillin-clavulanate (amoxicillin-clavulanate)
  • bedaquiline (bedaquiline)

Snippet

Sponsor: TASK Applied Science | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED